Purpose-built for physicians Q&A: Liraglutide outperforms colesevelam in reducing stool frequency in bile acid diarrhea Liraglutide reduced stool frequency in a small subset of patients with bile acid diarrhea and warrants consideration as a potential new treatment modality, according to research in The Lancet Gastroenterology and Hepatology
Improves digestion and gut health to combat the bloated feeling
No statistically significant difference was found in the medication indication, prescribed dosages, and length of taking the medication on this study
My results were good
Should additional safety concerns be identified, Health Canada will take appropriate action to protect public health and safety, including communicating updates, if needed
Include weekly weights, monthly measurements, any side effects and their severity, and notes on eating habits and activity levels